Figure 1

(A) Example temporal platelet count information of three patients with annotation of the date of diagnosis and primary treatment. (B) Each of the patient’s lab count information is discretized into the following time periods which include Prediag4, Prediag3, Prediag2, Prediag1, Postdiag and Treat, which are respectively fourth, third, second and first year time periods prior to the date of diagnosis, the time interval between the date of diagnosis and the date of the first intervention, and a three-month period following the intervention. (C) The size of the study population after incorporating more time periods for early and late stage lung cancer patients.